Contents

Current Signal Transduction Therapy, Volume 1 - Number 1

EDITORIAL

, 1(1): i - I

Gyorgy Keri and Axel Ullrich


DOI: 10.2174/157436206775269226




Signal Transduction Therapy for Cancer - Whither Now?

, 1(1): 1 - 12

Shoshana Klein and Alexander Levitzki


DOI: 10.2174/157436206775269244




Design and Development of Signal Transduction Inhibitors for Cancer Treatment: Experience and Challenges with Kinase Targets

, 1(1): 13 - 23

Ian Collins and Paul Workman


DOI: 10.2174/157436206775269181




Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy

, 1(1): 25 - 52

Bharat B. Aggarwal, Gautam Sethi, Asha Nair and Haruyo Ichikawa


DOI: 10.2174/157436206775269235




Epithelial Cell Signaling in Helicobacter pylori Infection

, 1(1): 53 - 65

Jean E. Crabtree and Michael Naumann


DOI: 10.2174/157436206775269253




Signal Transduction Therapy with Rationally Designed Kinase Inhibitors

, 1(1): 67 - 95

Gyorgy Keri, Laszlo Orfi, Daniel Eros, Balint Hegymegi-Barakonyi, Csaba Szantai-Kis, Zoltan Horvath, Frigyes Waczek, Jeno Marosfalvi, Istvan Szabadkai, Janos Pato, Zoltan Greff, Doris Hafenbradl, Henrik Daub, Gerhard Muller, Bert Klebl and Axel Ullrich


DOI: 10.2174/157436206775269190




Polypeptide and Protein Aggregates with Neurotoxic Properties in Neurodegenerative Disorders: Emphasis on β-Amyloid-Induced Dysfunction of Receptor-Mediated Signal Transduction Pathways

, 1(1): 97 - 112

Yann Verdier and Botond Penke


DOI: 10.2174/157436206775269208




Molecular Targeting of Cell Death Signal Transduction Pathways in Cancer

, 1(1): 113 - 131

Istvan Petak, Janet A. Houghton and Laszlo Kopper


DOI: 10.2174/157436206775269217




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science